Patent 7211267 was granted and assigned to Collagenex Pharmaceuticals, Inc. on May, 2007 by the United States Patent and Trademark Office.
A method of treating acne in a human in need thereof comprising administering systemically to said human a tetracycline compound in an amount that is effective to treat acne but has substantially no antibiotic activity, without administering a bisphosphonate compound.